CROs | Kisaco Research

CROs

Obesity and Metabolic Innovation Forum
4 December, 2024
Boston, MA

Why Should CROs Attend?

Download the agenda to see how you can stay informed about the latest therapeutic trends and precision medicine advancements crucial for R&D and product development.

DOWNLOAD AGENDA

  • Compare various GLP-1 drug combinations, their efficacy, safety, and patient outcomes.
  • Enhance trial design and execution to deliver better results for clients (CROs)
  • Learn about regulatory expectations to better align trial design and execution (CROs)

Top sessions for you

Transforming Obesity and Metabolic Health

Panel – Exploring the Pros and Cons of Difference GLP-1 Drug Combinations

Navigating Clinical Trial Design and Challenges

Regulatory challenges in development and approval of obesity drugs

Companies in our Community